-
International Journal of Chronic Obstructive Pulmonary Disease
-
Dr Pérez-López (Logout)
My Dovepress
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
ICS and COPD: Time to clear the air
(1295) Article views
Authors: Paul A Ford, Richard EK Russell, Peter J Barnes
Published Date July 2009 , Volume 2009:4 Pages 289 - 290 DOI 10.2147/COPD.S7143
Paul A Ford, Richard EK Russell, Peter J Barnes
Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK
The debate about what constitutes the correct treatment for COPD has recently intensified. This discussion has grumbled on ever since the first multicenter trials using inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) such as the European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP) and Inhaled Steroids in Obstructive Lung Disease (ISOLDE) were published in the late 1990’s and the results of trials such as TORCH (TOwards a Revolution in COPD Health) using combination products has only added to the confusion.
Other articles by Dr Richard Russell
Impact factor and its role in academic promotion- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
